2020
P13 Major depressive disorder in patients with wilson’s disease: relationship with liver disease, neurological disease and quality of life
Camarata M, Ala A, Maciejewski K, To U, Zimbrean P, Rubman S, Patel A, Wadhwa A, Coskun A, Apdik T, Tomlin R, Deng Y, Schilsky M. P13 Major depressive disorder in patients with wilson’s disease: relationship with liver disease, neurological disease and quality of life. Gut 2020, 69: a13-a13. DOI: 10.1136/gutjnl-2020-basl.24.Peer-Reviewed Original ResearchMajor depressive disorderQuality of lifeMental health QOLWilson's diseaseNeurological diseasesLiver diseaseDepressive disorderFirst presentationExact testDepression symptomologySeverity of liverLifetime major depressive disorderLiver disease severityFisher's exact testPhysical health QOLSignificant differencesWilcoxon rank sum testMental health problemsRank sum testFIB4 scoreClinical featuresNeurological assessmentPHQ-9PatientsCurrent depression
2015
Chapter 40 Myoclonus Classification, Clinical Features, and Genetics
Patel A, Frucht S. Chapter 40 Myoclonus Classification, Clinical Features, and Genetics. 2015, 655-670. DOI: 10.1016/b978-0-12-405195-9.00040-8.Peer-Reviewed Original ResearchHyperkinetic movement disordersClassification of myoclonusSite of pathologyMyoclonus physiologyClinical featuresNeurologic disordersEtiologic classificationMovement disordersMyoclonusParticular therapyNervous systemPeripheral centersParticular disorderDisordersGenetic heterogeneityTherapyEtiologyPhysiologyCliniciansDiagnosisPathologyPhysiologic